8.60Open8.60Pre Close0 Volume0 Open Interest102.00Strike Price0.00Turnover0.00%IV-16.98%PremiumApr 25, 2025Expiry Date22.16Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.63Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet